Literature DB >> 20881854

BMI and uterine size: is there any relationship?

Vani Dandolu1, Ruchira Singh, Jeff Lidicker, Oz Harmanli.   

Abstract

To evaluate the influence of BMI on the prevalence of fibroids and uterine weight. Uterine pathology specimens of all the women who underwent hysterectomy for benign indications from 1995 to 2002 were studied. Patient characteristics such as age, race, body mass index (BMI), and parity were collected by chart review. The data were statistically analyzed using a 1-way analysis of variance and regression analysis. Uterine weight and fibroids were the dependent variables and BMI, age, and parity were the independent variables. The correlation between BMI and the presence/number of fibroids and their size was also studied. Among the 873 patients who underwent hysterectomy for benign indications, 47.1% were obese and these women had the highest mean uterine weight of 349.53 g. Overall, BMI had a significant correlation with the uterine size (P<0.0001). For every 1-point increase in BMI, uterine weight increased by 7.56 g. BMI positively correlated with uterine size both in the women with fibroids (P=0.038) and in those without fibroids (P=0.016). After controlling for fibroids, every 1-point increase in BMI resulted in an increase of 4.56 g in uterine weight (P<0.0001). In addition, there was a significant correlation between BMI and the presence of fibroids (P<0.0001), but not with the size of fibroids (P=0.11). A significant correlation was found between BMI and uterine weight in all the women, independent of age and parity. For every 1-point increase in BMI, there was a 7.56 g increase in uterine weight. This association needs to be further assessed in healthy women without uterine pathology.

Entities:  

Mesh:

Year:  2010        PMID: 20881854     DOI: 10.1097/PGP.0b013e3181e8ae64

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

1.  Evaluating risk factors for differences in fibroid size and number using a large electronic health record population.

Authors:  Michael J Bray; Eric S Torstenson; Sarah H Jones; Todd L Edwards; Digna R Velez Edwards
Journal:  Maturitas       Date:  2018-05-11       Impact factor: 4.342

Review 2.  Hysterectomy in very obese and morbidly obese patients: a systematic review with cumulative analysis of comparative studies.

Authors:  Mathijs D Blikkendaal; Evelyn M Schepers; Erik W van Zwet; Andries R H Twijnstra; Frank Willem Jansen
Journal:  Arch Gynecol Obstet       Date:  2015-03-13       Impact factor: 2.344

3.  Effects of obesity and hormone therapy on surgically-confirmed fibroids in postmenopausal women.

Authors:  Eva M Sommer; Angela Balkwill; Gillian Reeves; Jane Green; Dame Valerie Beral; Kate Coffey
Journal:  Eur J Epidemiol       Date:  2015-03-18       Impact factor: 8.082

4.  Uterine dimensions in gravida 0 phase according to age, body mass index, and height in Chinese infertile women.

Authors:  Hong Gao; Dong-E Liu; Yumei Li; Jing Tang; Shimin Hu; Xinrui Wu; Zhengwen Tian; Hongzhuan Tan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

5.  Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.

Authors:  Ayman Al-Hendy; Linda Bradley; Charlotte D Owens; Hui Wang; Kurt T Barnhart; Eve Feinberg; William D Schlaff; Elizabeth E Puscheck; Alice Wang; Veronica Gillispie; Sandra Hurtado; Ozgul Muneyyirci-Delale; David F Archer; Bruce R Carr; James A Simon; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2020-07-20       Impact factor: 8.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.